Short mutations (single nucleotide or short insertions/deletions) in BRCA1/2 within the tumor (tBRCA*), which can reveal either gBRCA* or sBRCA* are estimated to be present in approximately 20–25% of cases [14,15]. The gene discussed is BRCA1; the disease is neoplasm.